NCC Global | Revolutionizes Market Entry at WHX Dubai 2026 with Innovative "Zero-Capex" Partnership Model

DUBAI, Feb 12, 2026 — NCC Medical（诺诚电生理）concluded a highly successful showcase at WHX Dubai 2026. Beyond presenting its comprehensive neurophysiology portfolio, the company made waves by introducing a strategic commercial policy designed to empower global distributors, resulting in over 100+ high-quality leads from the MENA region and beyond.

Cutting-Edge Portfolio on Display

NCC Medical presented its full suite of neuro-diagnostic and monitoring solutions, catering to the evolving needs of modern hospitals:

• Intraoperative Neuromonitoring (IONM): The flagship Cynapse IONM and Smart IONM systems highlighted our commitment to patient safety during complex surgeries.

• Clinical Diagnostics: Advanced EEG, EMG, and Wireless PSG systems demonstrated our leading position in neuro-diagnostic technology.

• Rehabilitation & Research: The Wireless Surface EMG garnered praise for its portability and high-fidelity signal acquisition.

Strategic Initiative: "Buy Consumables, Get Free IONM System"

To accelerate clinical adoption and support our partners, NCC Medical officially launched its "Buy Consumables, Get Free IONM System" program at the event.

• Lowering Barriers: This initiative is specifically designed to eliminate the heavy upfront capital expenditure (CAPEX) for equipment.
• Accelerated ROI: By shifting to an OPEX-friendly model, distributors can enter the market faster and focus on clinical service and market penetration, ensuring a more rapid return on investment.

Global Partnership Opportunities While the Middle East remains a key focus, the overwhelming interest from international delegates underscores the global demand for NCC’s solutions. NCC Medical is currently seeking professional distributors worldwide. We provide our partners with robust technical support, comprehensive training, and industry-leading commercial incentives.

About NCC Medical Co.,Ltd

     For 28 years, NCC Medical has focused on tackling key challenges in electrophysiological technology and developing related products. Adhering to the core value of "Commitment,Sincerity,Integrity," the company has continuously launched high-end electrophysiological equipment with independent intellectual property rights, driving the development of the electrophysiology industry. Its independently developed product—the first domestically made neurostimulation monitor specifically designed for intraoperative use in orthopedics and neurosurgery—has achieved a major breakthrough in domestic manufacturing and broken the barrier of reliance on imported equipment. Looking ahead, in the field of intraoperative electrophysiology, NCC Medical aims to strengthen industry-academia-research cooperation with clinical institutions, advance the development of cutting-edge technologies in this field, and provide higher-quality services for patients.

     As a "National-level Specialized, Refined, Differential, and Innovative Little Giant Enterprise" recognized by the Ministry of Industry and Information Technology, NCC Medical has always adhered to independent innovation and lean manufacturing, and built a full-chain independent and controllable system covering core technology R&D to key component production. The company's consumables subsidiary, Shanghai Yingshou Medical Device Co., Ltd., has also been awarded the title of "Shanghai Municipal-level Specialized, Refined, Differential, and Innovative Little Giant Enterprise", which further strengthens the company's leading advantages in the collaborative innovation of equipment and consumables.

     NCC Medical attaches great importance to technological innovation and clinical value. Its independently developed intraoperative  neuromonitoring and 256 high-channel event-related potential digital EEG capable of assisting cognitive diagnosis have both been included in the Shanghai Innovative Medical Devices Catalog . This marks that the products have obtained authoritative recognition in terms of technological advancement, clinical urgency, and quality and safety standards.